A study found mutations that cause SMA may trigger problems with bone cell communication, suggesting a potential new way to treat weak bones.

The discovery of a family with sequence similarity 102 member A (Fam102a) protein as a novel bone remodeling factor that regulates both osteoclast and osteoblast differentiation can aid the ...

“[...] chlorogenic acid appears to be a promising candidate for the management of osteoporosis.” Osteoporosis is a common bone disease in aging populations ...

A transformative study has uncovered the pivotal role of the protein Naked cuticle homolog 2 (NKD2) in regulating the differentiation of bone-forming osteoblasts and bone-resorbing osteoclasts. This ...

It’s estimated more than 10 million Americans over the age of 50 live with osteoporosis, a bone disease that causes the bones to become weak and brittle. Osteoporosis, in and of itself, isn’t usually ...

Birmingham researchers have shown PEPITEM, a naturally occurring peptide (small protein) holds promise as a new therapeutic for osteoporosis and other disorders that feature bone loss, with distinct ...